US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 57 | 35 | 84 | 115 | 65 |
| Cost of Goods | 14 | 14 | 16 | 11 | 19 |
| Gross Profit | 43 | 22 | 69 | 105 | 46 |
| Operating Expenses | 562 | 817 | 572 | 556 | 1,058 |
| Operating Income | -505 | -781 | -487 | -440 | -993 |
| Interest Expense | 163 | 167 | 155 | 149 | 153 |
| Other Income | -5 | -46 | -338 | 0 | -10 |
| Pre-tax Income | -672 | -994 | -980 | -590 | -1,156 |
| Net Income Continuous | -672 | -994 | -980 | -590 | -1,156 |
| Net Income | $-672 | $-994 | $-980 | $-590 | $-1,156 |
| EBITDA(a) | $-348 | $-618 | $-340 | $-302 | $-850 |